Daicel Corporation (TYO:4202)

Market Cap	312.06B
Revenue (ttm)	586.53B
Net Income (ttm)	49.48B
Shares Out	265.13M
EPS (ttm)	181.44
PE Ratio	6.49
Forward PE	5.60
Dividend	60.00 (5.11%)
Ex-Dividend Date	Mar 28, 2025

Volume	339,900
Average Volume	580,110
Open	1,181.00
Previous Close	1,177.00
Day's Range	1,178.00 - 1,186.00
52-Week Range	1,057.50 - 1,610.50
Beta	0.22
RSI	40.88
Earnings Date	Aug 1, 2025

About Daicel

Daicel Corporation engages in the materials, medical/healthcare, smart, safety, engineering plastics, and other businesses in Japan, China, and internationally. The company offers acetic acid, acetic acid derivative chemicals, acetate tow, acetic anhydride, thioglycolic acid, caprolactone derivatives, methyl 3-methoxyacrylate, cycloaliphatic epoxies, alkylamines comprising diethylhydroxyamine, and 1,3-butylene glycol, as well as cellulose acetate; and Actranza Lab, a drug delivery device. It also provides solutions for the electronics market, s...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1919
• Employees: 11,178
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4202

Financial Performance

In 2024, Daicel's revenue was 586.53 billion, an increase of 5.10% compared to the previous year's 558.06 billion. Earnings were 49.48 billion, a decrease of -11.38%.